Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Explore Visualizing Your Financial Goals to turn abstract aims into concrete visuals, aiding commitment and progress tracking.
21,085 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
SpaceX is pursuing a bold mix of rockets, Starlink, and AI infrastructure. Yet heavy capital needs and a large debt l...
A major institution disclosed a new roughly $5 million stake in Central Bancompany, helping fuel a 20% gain since its...
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
Blink Charging's Q1 2026 earnings set the tone for the year. This article breaks down what to watch, how to read the ...
A new wave of legal challenges has hit kardashian’s skims with lawsuit, shaking up the brand’s polished image. This a...
A fresh look at retirement rules shows social security’s hidden formula reduces replacement rates for high earners, u...
A five-year plumbing dispute in a premium Manhattan co-op escalates into questions about the building’s finances. Thi...
A veteran police captain faced a fake warrant scam and chose to record the conversation. The incident reveals the tel...
As we enter June, investors wonder if summer headwinds are already priced into stocks. This article breaks down prici...
A growth stock down dip can open the door to meaningful long-term gains. Learn how to assess, plan, and act with conf...
Two of the biggest S&P 500 ETFs dominate the core holdings landscape. This guide breaks down how Vanguard and iShares...